Skip to content ↓

Two TCF events on April 7

The Technology and Culture Forum will present two events on Tuesday, April 7, one on climate change and the other on electronic privacy. Both are in Wong Auditorium (Building E51).

"The Science and Policy of Climate Change: Where Are We After Kyoto?" at 4pm in Wong Auditorium will feature Henry Jacoby, the Pounds Professor of Management at the Sloan School; Ronald Prinn, the TEPCO Professor of Atmospheric Chemistry; and Kilaparti Ramakrishna, director of the Program on Science in Public Affairs at the Woods Hole Research Center and special advisor to the United Nations for the recent climate treaty. Professors Jacoby and Prinn are co-directors of the MIT Joint Program on the Science and Policy ofGlobal Change.

At 7pm, three speakers will discuss "Privacy on the Line: The Politics of Wiretapping and Encryption." They are Whitfield Diffie, an engineer at Sun Microsystems; Associate Professor Susan Landau of the Department of Computer Science, University of Massachusetts at Amherst; and Ronald Rivest, the E.S. Webster Professor of Electrical Engineering and Computer Science and associate director of the Laboratory for Computer Science. The moderator will be Hal Abelson, the Class of 1922 Professor of Electrical Engineering and Computer Science.

Both programs are free and open to the public; no registration is required. For more information, call x3-0108.

A version of this article appeared in MIT Tech Talk on April 1, 1998.

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story